Page 2 - Our Research Development News Today

Investegate announcements from Sanofi - Aventis Groupe, Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver

Tomorrow, Sanofi will host an Immunology Investor Event with key members of the leadership team providing updates on how the company is advancing its Immunology strategy, including the ambition to more than quadruple Immunology franchise sales by the end of the decade. The focus of the event is on Dupixent® ...

From the blog of Omri Hurwitz at The Times of Israel

Mary Kay Unveils Skin Health Grants, Breakthrough Retinol Research at 2021 Society for Investigative Dermatology Conference on May 10 2021 11:03 PM DALLAS--(BUSINESS WIRE)--Mary Kay Inc., a global leader in skin care innovation, continued its ongoing support of the beauty and scientific communities recently by sponsoring the virtual 2021 Society for Investigative Dermatology (SID) Annual Meeting, helping fund the society’s virtual meeting platform. At the meeting, Mary Kay unveiled breakthrou...

Above The Law In your inbox Subscribe and get breaking news, commentary, and opinions on law firms, lawyers, law schools, lawsuits, judges, and more. We will never sell or share your information without your consent. See our privacy policy. Games People Play: CLE Levels Up With Learning Science People learn better when they can interact meaningfully with the material – this is as true for CLE as it is in law school. By JC Kinnamon, Ph.D., Director, Research & Development - Practising Law In...